Drink alcohol frequently?

You could qualify for a research study at NIDA.

We are seeking study participants who are at least 18 years old and drink alcohol on a regular basis.

Study Name

Semaglutide Therapy for Alcohol Reduction (STAR): A Proof-of-Concept Phase II
Study# 001603
Nickname: STAR-B

Purpose

We are testing an experimental drug named semaglutide to see if it is safe in people with alcohol problems. We also want to find out if the study drug reduces drinking, and how well people respond to the study drug.

Length of Study

20 weekly outpatient visits and 2 follow up visits approximately 3 and 7 weeks after the last study drug dose

Study Activities

Taking semaglutide (Ozempic® or Wegovy®) and/or placebo shots once a week, behavioral therapy modules, questionnaires, medical history evaluation, diagnostic specimen collection (blood, urine, and saliva), brain magnetic resonance imaging (MRI) scans, electrocardiograms (ECG), and participating in a bar-like laboratory and buffet-like virtual reality tasks.

Compensation

Up to $4,400.

Local Travel

Will be provided (via Uber Health) or reimbursed.

More information about this study is available here.